FY25 award. Nida developmental studies biorepository and analysis center. September 17, 2025 - september 16, 2026. N01DA-21-5588. Task order 75N95025F00001 (TO5).
Ended Awarded Last action
- Contract number
- 75N95025F00001
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,098,888
Award facts
- Opportunity
-
- 75N95F00001 Solicitation number
- Contract value 100% obligated
- $6,098,888.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- West McLean, VA 22102, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute on Drug Abuse (NIDA) awarded a $6.1M delivery order (Task Order 75N95025F00001) to Booz Allen Hamilton Inc. for the FY25 NIDA Developmental Studies Biorepository and Analysis Center, effective September 17, 2025 through September 16, 2026. This firm fixed-price contract was awarded without a set-aside designation and will be performed at Booz Allen Hamilton's facility in West McLean, Virginia. The award represents a continuation of support for NIDA's biorepository initiatives, which maintain critical biological specimen collections and analytical capabilities essential to the institute's drug abuse research programs.
Booz Allen Hamilton has engaged Infinity Biologix LLC (doing business as Sampled Division), a specialized biomedical research services provider based in Piscataway, New Jersey, as a major subcontractor for sample biostorage and laboratory services under this award. Infinity Biologix brings extensive expertise in genomic analysis, biorepository solutions, and high-complexity laboratory services, with established experience supporting NIDA and other National Institutes of Health components. This subcontracting arrangement leverages complementary capabilities to deliver comprehensive biorepository management and analytical support for NIDA's developmental studies research portfolio.
Quick answers
Who was awarded contract 75N95025F00001?
75N95025F00001 was awarded to Booz Allen Hamilton Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 17, 2025.
How much is contract 75N95025F00001 worth?
The government has obligated $6,098,888 on 75N95025F00001.
Is contract 75N95025F00001 an order under another contract?
Yes. 75N95025F00001 is a delivery order under 75N95021D00023, an indefinite delivery contract.
Was contract 75N95025F00001 competed?
The extent of competition for 75N95025F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award